Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elaeagnus angustifolia extract for after-pains following normal delivery
IRCT20230608058428N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of elaeagnus angustifolia extract in Afterpains, sponsored by Mashhad University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
elaeagnus angustifolia extract
03
Conditions
Afterpains
Beyond the preview
Go deeper on IRCT20230608058428N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230608058428N1.